Connecticut's Office of Health Strategy fines Johnson Memorial Hospital $153,500 for ending labor and delivery services without approval.

Neumora Therapeutics announced that its antidepressant candidate, navacaprant, did not meet the primary endpoint in a Phase 3 study for major depressive disorder.

Eli Lilly is joining in a lawsuit filed by the Outsourcing Facilities against the FDA, aiming to reverse the FDA's October 2024 determination that the shortage has been resolved, which would allow ...

Discover a new experimental nasal swab that can accurately differentiate between various types of asthma, potentially revolutionizing diagnosis and treatment.